Доступ предоставлен для: Guest
Critical Reviews™ in Oncogenesis
Главный редактор: Benjamin Bonavida (open in a new tab)

Выходит 4 номеров в год

ISSN Печать: 0893-9675

ISSN Онлайн: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Получить доступ(open in a new tab)
Более
Приобрести $40.00(open in a new tab) Проверить подписку Скачать MARC запись(open in a new tab) Получить разрешения(open in a new tab)

Understanding the Biology of CRLF2-Overexpressing Acute Lymphoblastic Leukemia

Том 16, Выпуск 1-2, 2011, pp. 13-24
DOI: 10.1615/CritRevOncog.v16.i1-2.30
Get accessGet access
Sarah Tasian
The Children's Hospital of Philadelphia
Mignon L. Loh
Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California San Francisco, San Francisco, California

Краткое описание

Recent genomic analyses of childhood and adult B-precursor acute lymphoblastic leukemia (ALL) samples have identified novel genetic alterations in essential lymphoid development and signal transduction pathways, providing insight into the pathogenesis of high-risk ALL associated with treatment failure. Particular advances have been made in unraveling the genetics of ALL associated with overexpression of the cytokine receptor-like factor 2 gene (CRLF2), which is frequently accompanied by simultaneous activating mutations in genes encoding Ikaros (IKZF1), Janus kinase 1 (JAK1) and Janus kinase 2 (JAK2), and/or the IL-7 receptor alpha chain (IL7RA). Children and adults with high-risk CRLF2-overexpressing ALL have high rates of relapse and dismal overall survival. Various groups have thus attempted to characterize the biochemical consequences of these genetic lesions via preclinical models with the goal of identifying targets for new therapies. These studies provide early data suggesting the promise of signal transduction inhibitors (STIs) of the JAK/STAT and PI3K pathways for CRLF2-overexpressing ALL. Additional research efforts continue to elucidate these aberrant signaling networks to provide rationale for bringing STIs into the clinic for these high-risk patients. This review highlights the current knowledge of the incidence, prognostic significance, and biology of CRLF2-overexpressing ALL and future directions for development of targeted therapies.

Ключевые слова: acute lymphoblastic leukemia, CRLF2, JAK2, signal transduction, TSLP, TSLPR
ЦИТИРОВАНО В

  1. Tasian Sarah K., Doral Michelle Y., Borowitz Michael J., Wood Brent L., Chen I-Ming, Harvey Richard C., Gastier-Foster Julie M., Willman Cheryl L., Hunger Stephen P., Mullighan Charles G., Loh Mignon L., Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia, Blood, 120, 4, 2012. Crossref

  2. Ziegler Steven F., Roan Florence, Bell Bryan D., Stoklasek Thomas A., Kitajima Masayuki, Han Hongwei, The Biology of Thymic Stromal Lymphopoietin (TSLP), in Immunopharmacology, 66, 2013. Crossref

  3. Raghunathan Rekha, Mahesula Swetha, Kancharla Kranthi, Janardhanan Preethi, Jadhav Yeshwant L. A., Nadeau Robert, Villa German P., Cook Robert L., Witt Colleen M., Gelfond Jonathan A. L., Forsthuber Thomas G., Haskins William E., Anti-CRLF2 Antibody-Armored Biodegradable Nanoparticles for Childhood B-ALL, Particle & Particle Systems Characterization, 30, 4, 2013. Crossref

  4. Jayaraman Archana, Jamil Kaiser, Khan Haseeb A., Identifying new targets in leukemogenesis using computational approaches, Saudi Journal of Biological Sciences, 22, 5, 2015. Crossref

  5. Qin Haiying, Cho Monica, Haso Waleed, Zhang Ling, Tasian Sarah K., Oo Htoo Zarni, Negri Gian Luca, Lin Yongshun, Zou Jizhong, Mallon Barbara S., Maude Shannon, Teachey David T., Barrett David M., Orentas Rimas J., Daugaard Mads, Sorensen Poul H. B., Grupp Stephan A., Fry Terry J., Eradication of B-ALL using chimeric antigen receptor–expressing T cells targeting the TSLPR oncoprotein, Blood, 126, 5, 2015. Crossref

  6. Dou Hu, Chen Xi, Huang Yi, Su Yongchun, Lu Ling, Yu Jie, Yin Yibing, Bao Liming, Prognostic significance ofP2RY8-CRLF2andCRLF2overexpression may vary across risk subgroups of childhood B-cell acute lymphoblastic leukemia, Genes, Chromosomes and Cancer, 56, 2, 2017. Crossref

  7. Sadras Teresa, Heatley Susan L., Kok Chung H., McClure Barbara J., Yeung David, Hughes Timothy P., Sutton Rosemary, Ziegler David S., White Deborah L., A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH, Cancer Genetics, 216-217, 2017. Crossref

  8. Tasian Sarah K., Teachey David T., Li Yong, Shen Feng, Harvey Richard C., Chen I-Ming, Ryan Theresa, Vincent Tiffaney L., Willman Cheryl L., Perl Alexander E., Hunger Stephen P., Loh Mignon L., Carroll Martin, Grupp Stephan A., Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia, Blood, 129, 2, 2017. Crossref

  9. Vainchenker William, Leroy Emilie, Gilles Laure, Marty Caroline, Plo Isabelle, Constantinescu Stefan N., JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders, F1000Research, 7, 2018. Crossref

  10. Mangaonkar Abhishek A., Patnaik Mrinal M., Oliver Gavin R., Rao Kathleen W., Kaiser-Rogers Kathleen, Davila Jaime I., Fadra Numrah, Wehrs Rebecca N., Elliott Michelle A., Greipp Patricia T., Halling Kevin C., Van Dyke Daniel L., Multiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target, Leukemia & Lymphoma, 60, 3, 2019. Crossref

  11. Ziegler Steven F., Roan Florence, Bell Bryan D., Stoklasek Thomas A., Kitajima Masayuki, Han Hongwei, Thymic Stromal Lymphopoietin (TSLP), in Cytokine Frontiers, 2014. Crossref

  12. Madzio Joanna, Pastorczak Agata, Sedek Lukasz, Braun Marcin, Taha Joanna, Wypyszczak Kamila, Trelinska Joanna, Lejman Monika, Muszynska‐Roslan Katarzyna, Tomasik Bartlomiej, Derwich Katarzyna, Koltan Andrzej, Kazanowska Bernarda, Irga‐Jaworska Nina, Badowska Wanda, Matysiak Michal, Kowalczyk Jerzy, Styczynski Jan, Fendler Wojciech, Szczepanski Tomasz, Mlynarski Wojciech, GATA3germline variant is associated withCRLF2expression and predicts outcome in pediatric B‐cell precursor acute lymphoblastic leukemia, Genes, Chromosomes and Cancer, 2019. Crossref

  13. Akın Balı Dilara Fatma, Pediatrik öncü B-ALL’ye Moleküler Yaklaşım, Zeynep Kamil Tıp Bülteni, 2019. Crossref

  14. Peker Deniz, Tao Jianguo, Zhang Ling, Molecular Diagnostics of Lymphoid Neoplasms, in Molecular Pathology and Diagnostics of Cancer, 2014. Crossref

  15. Felicio Paula Silva, Bidinotto Lucas Tadeu, Melendez Matias Eliseo, Grasel Rebeca Silveira, Campacci Natalia, Galvão Henrique C.R., Scapulatempo-Neto Cristovam, Dufloth Rozany Mucha, Evangelista Adriane Feijó, Palmero Edenir Inêz, Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population, Oncotarget, 9, 44, 2018. Crossref

  16. Ge Zheng, Gu Yan, Zhao Gang, Li Jianyong, Chen Baoan, Han Qi, Guo Xing, Liu Juan, Li Hui, Yu Michael D., Olson Justin, Steffens Sadie, Payne Kimberly J., Song Chunhua, Dovat Sinisa, High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement, Oncotarget, 7, 31, 2016. Crossref

  17. Weng Stephanie, Stoner Samuel A., Zhang Dong-Er, Sex chromosome loss and the pseudoautosomal region genes in hematological malignancies, Oncotarget, 7, 44, 2016. Crossref

  18. Borowitz Michael J., Flow Cytometry in Oncologic Diagnosis, in Abeloff's Clinical Oncology, 2014. Crossref

  19. Naji Parisa, Sheikhpour Mojgan, Movafagh Abolfazl, Gene mutation of childhood B-acute lymphoblastic leukemia: A systematic review, Clinical Cancer Investigation Journal, 9, 5, 2020. Crossref

  20. Asare Julie M., Rabik Cara A., Muller Bradley, Brown Patrick A., Cooper Stacy, Investigational treatment options in phase I and phase II trials for relapsed or refractory acute lymphoblastic leukemia in pediatric patients, Expert Opinion on Investigational Drugs, 30, 6, 2021. Crossref

  21. Thakral Beenu, Jain Nitin, Tang Guilin, Konoplev Sergej, Vega Francisco, Medeiros L. Jeffrey, Wang Sa A., From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia, Annals of Diagnostic Pathology, 53, 2021. Crossref

  22. Lee Shawn H. R., Li Zhenhua, Tai Si Ting, Oh Bernice L. Z., Yeoh Allen E. J., Genetic Alterations in Childhood Acute Lymphoblastic Leukemia: Interactions with Clinical Features and Treatment Response, Cancers, 13, 16, 2021. Crossref

  23. Constantinescu Stefan N, Vainchenker William, JAK / STAT Signalling and Haematological Malignancies , in eLS, 2015. Crossref

  24. He Bing, Gao Peng, Ding Yang-Yang, Chen Chia-Hui, Chen Gregory, Chen Changya, Kim Hannah, Tasian Sarah K., Hunger Stephen P., Tan Kai, Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers, Science Advances, 6, 30, 2020. Crossref

  25. Page Elyse C., Heatley Susan L., Eadie Laura N., McClure Barbara J., de Bock Charles E., Omari Sofia, Yeung David T., Hughes Timothy P., Thomas Paul Q., White Deborah L., HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort, Oncogene, 41, 6, 2022. Crossref

  26. Rastogi Pulkit, Bhatia Prateek, Sreedharanunni Sreejesh, Lad Deepesh, A look inside the body of a BCR-ABL1-like acute lymphoblastic leukemia patient: the first case report highlighting the continued relevance of autopsy practice, BLOOD RESEARCH, 56, 4, 2021. Crossref

  27. Downes Charlotte EJ., McClure Barbara J., McDougal Daniel P., Heatley Susan L., Bruning John B., Thomas Daniel, Yeung David T., White Deborah L., JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies, Frontiers in Cell and Developmental Biology, 10, 2022. Crossref

  28. Hassan Naglaa M., El Ashry Mona S., Abdellateif Mona, Hassan Reem Nabil, Evaluating the Role of Cytokine Receptor-like Factor 2 and Janus Kinase 2 in Adult Acute Lymphoblastic Leukemia, Open Access Macedonian Journal of Medical Sciences, 10, B, 2022. Crossref

  29. Alkashgari Hossam R., Ruiz-Jimenez Caleb, Stoian Cornelia, Coats Jacqueline S., Baez Ineavely, Chirshev Evgeny, Martinez Shannalee R., Dovat Sinisa, Francis-Boyle Olivia L., Casiano Carlos A., Payne Kimberly J., TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia, International Journal of Molecular Sciences, 24, 1, 2022. Crossref

1600 Просмотры статей 77 Загрузка статей Метрики
1600 ПРОСМОТРЫ 77 ЗАГРУЗКИ 29 Crossref ЦИТАТЫ Google
Scholar ЦИТАТЫ

Статьи с похожим содержанием:

Gaucher Disease and Myeloma Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 3
Derralynn A. Hughes, Robert Ayto
Homeobox Gene Involvement in Normal Hematopoiesis and in the Pathogenesis of Childhood Leukemias Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 3-4
Vassilis Zoumpourlis, Ioannis Christodoulou, Maria Adamaki, Maria Goulielmaki, Spiros Vlahopoulos
Genes Associated with Human Cancers: Their Expressions, Features, Functions, and Significance Critical Reviews™ in Eukaryotic Gene Expression, Vol.25, 2015, issue 3
Ravi Maddaly, Bellona Sahu, Divya K. Mohan
Strategies to Strike Survival Networks in Cancer Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 3-4
Marzia Pennati, Giuliana Cassinelli, Graziella Cimino-Reale, Laura Gatti
Angiogenesis: Promising Therapeutic Target of Metastatic Colon Cancer Critical Reviews™ in Oncogenesis, Vol.25, 2020, issue 2
Rama Rao Malla, Rakshmitha Marni

Последний выпуск

Machine Evaluation of Catchment Area Relevance through Text Mining Philip A. Arlen, Joseph Chakko, Geoffrey DeGennaro, Erin Kobetz, Brandon Mahal Oral Cavity Squamous Cell Carcinoma: Review of Pathology, Diagnosis, and Management Benjamin J. Rich, Stuart E. Samuels, Gregory A. Azzam, Gregory Kubicek, Laura Freedman Surgical Management of the Neck in Oral Cavity Squamous Cell Carcinoma Olivia Mihulka, Eric Nisenbaum, Elizabeth Nicolli Convolutional Neural Networks for Glioma Segmentation and Prognosis: A Systematic Review Janette Herr, Radka Stoyanova, Eric Albert Mellon Proton Beam Therapy for Breast Cancer Seraphina Choi, Isabella Dreyfuss, Crystal Seldon Taswell, Jonathan Cyriac, Michael Butkus, Cristiane Takita Management of Advanced Medullary Thyroid Carcinoma: Current Systemic Therapy Options Mark A. Jara Disparities in Electronic Cigarette Use: A Narrative Review Kyle Edwards, Aysswarya Manoharan, Taghrid Asfar, Samuel Kareff, Gilberto Lopes, Estelamari Rodriguez, Coral Olazagasti The Genetic Paradigm of Hereditary Breast and Ovarian Cancer (HBOC) in the Afro-Caribbean Population Danielle Cerbon, Daphanie Taylor, Priscila Barreto-Coelho, Estelamari Rodriguez, Matthew Schlumbrecht, Judith Hurley, Sophia H.L. George

Статьи, принятые к публикации

Neuroplasticity: Pathophysiology and Role in Major Depressive Disorder Rama Rao Malla, Sreeharshini Kadiyala, Priyamvada Bhamidipati IMMUNE EVASION IN CANCER IS REGULATED BY THE TUMOR-ASOCIATED MACROPHAGES (TAMS): TARGETING TAMS Megan Jung, Benjamin Bonavida Disparities in Electronic Cigarette Use: A Narrative Review Kyle Edwards, Aysswarya Manoharan, Taghrid Asfar, Samuel Kareff, Gilberto Lopes, Estelamari Rodriguez, Coral Olazagasti Advanced Medullary Thyroid Carcinoma: The Current Systemic Therapy Options Mark Jara Proton Beam Therapy for Breast Cancer Seraphina Choi, Crystal Taswell, Isabella Dreyfuss, Jonathan Cyriac, Michael Butkus, Cristiane Takita The Genetic Paradigm of Hereditary Breast and Ovarian Cancer in The Afro-Caribbean Population Danielle Cerbon, Daphnie Taylor, Priscila Barreto Coelho, Estelamari Rodriguez, Matthew Schlumbrecht, Judith Hurley, Sophia George
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain